| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Ligand | BDBM375307 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Activity Assay |
|---|
| IC50 | >3330±n/a nM |
|---|
| Citation |  Treon, SP; Buhrlage, SJ; Gray, NS; Tan, L; Yang, G Methods to treat lymphoplasmacytic lymphoma US Patent US10597387 Publication Date 3/24/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Nuclear receptor subfamily 2 group C member 2 |
|---|
| Name: | Nuclear receptor subfamily 2 group C member 2 |
|---|
| Synonyms: | NR2C2 | NR2C2_HUMAN | Nuclear receptor subfamily 2 group C member 2 | Nuclear receptor subfamily 2 group C member 2 (TAK1) | TAK1 | TR4 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 65411.75 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1476357 |
|---|
| Residue: | 596 |
|---|
| Sequence: | MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG
TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC
GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM
GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL
DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ
PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP
LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR
ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN
SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRL
ARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL
|
|
|
|---|
| BDBM375307 |
|---|
| n/a |
|---|
| Name | BDBM375307 |
|---|
| Synonyms: | US10597387, Compound (I-6) | US9908872, Compound (I-6) |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H24N4O2S |
|---|
| Mol. Mass. | 480.581 |
|---|
| SMILES | Cc1ccc(cc1NC(=O)c1cncc(c1)-c1cccs1)C(=O)Nc1cccc(c1)C(C)(C)C#N |
|---|
| Structure | 
|
|---|
Search and Browse
